Shedding light on hidden muscle fat: can weight loss quiet inflammation?

NCT ID NCT06129110

First seen May 08, 2026 · Last updated Jun 20, 2026 · Updated 11 times

Summary

This study looks at how weight loss changes the fat stored inside muscles, called IMAT, in people with obesity. Researchers want to see if losing weight reduces harmful signals from this fat that can lead to insulin resistance and muscle weakness. Seventy participants will follow a 12-week low-calorie diet and undergo tests including muscle biopsies, MRIs, and strength measurements before and after weight loss.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Colorado Anschutz

    RECRUITING

    Aurora, Colorado, 80045, United States

    Contact

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Low calorie diet of meal replacement shakes

What this could lead to

If successful, this could reveal how fat inside muscles contributes to insulin resistance and muscle weakness, pointing toward new ways to prevent or treat these conditions.

What could go wrong

This is a small, early-stage study focused on understanding mechanisms, not testing a treatment. Results may not apply to everyone, and weight loss may not change the fat signals as expected.

Conditions

The condition(s) this trial relates to.

Insulin Resistance Muscle Weakness Obesity obesity disorder Weight Loss

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.